Correspondence 0001104659-24-098569 from Zenas BioPharma, Inc. (ZBIO) (CIK 0001953926) (ZBIO)
Zenas BioPharma, Inc. (ZBIO) (CIK 0001953926)
Date: Sept. 10, 2024 · CIK: 0001953926 · Accession: 0001104659-24-098569
AI Filing Summary & Sentiment
File numbers found in text: 333-281713
Letter
ZENAS BIOPHARMA, Inc.
1000 Winter Street, Suite 1200
Waltham, MA 02451
September 10, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tyler Howes and Chris Edwards, Division of Corporation Finance
Re: Zenas BioPharma, Inc.
Registration Statement on Form S-1, as amended (File No. 333-281713)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Zenas BioPharma, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on September 12, 2024, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski or Nicholas Roper of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Thomas Danielski or Nicholas Roper of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 or (617) 951-7116, as soon as the registration statement has been declared effective.
[Signature page follows]
Very truly yours,
ZENAS BIOPHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
ZENAS
BIOPHARMA, Inc.
1000 Winter Street, Suite 1200
Waltham, MA 02451
September 10, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Tyler Howes and Chris Edwards, Division of Corporation Finance
Re: Zenas BioPharma, Inc.
Registration Statement on Form S-1, as amended (File No. 333-281713)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Zenas BioPharma, Inc., a Delaware corporation (the “Company”), hereby requests that the
effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern
Time on September 12, 2024, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski or Nicholas Roper of
Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Thomas Danielski or Nicholas Roper
of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 or (617) 951-7116, as soon as the registration statement has been
declared effective.
[Signature page follows]
Very truly yours,
ZENAS BIOPHARMA, INC.
By:
/s/ Leon O. Moulder, Jr.
Name:
Leon O. Moulder, Jr.
Title:
Chief Executive Officer
cc.
Joseph Farmer (Zenas BioPharma, Inc.)
cc.
Thomas Danielski (Ropes & Gray LLP)
cc.
Nicholas Roper (Ropes & Gray LLP)
cc.
Richard Segal (Cooley LLP)
cc.
Denny Won (Cooley LLP)
[Signature Page to Acceleration Request]